Business Description

Description
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.19
Equity-to-Asset 0.71
Debt-to-Equity 0.26
Debt-to-EBITDA -0.45
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.54
Distress
Grey
Safe
Beneish M-Score -3.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 88.95
9-Day RSI 71.09
14-Day RSI 56.78
6-1 Month Momentum % -95.65
12-1 Month Momentum % -96.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.99
Quick Ratio 0.5
Cash Ratio 0.12
Days Inventory 279.91
Days Sales Outstanding 53.16
Days Payable 100.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -71.5
Shareholder Yield % -14.1

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 44.35
Operating Margin % -115.06
Net Margin % -115.87
FCF Margin % -60.58
ROE % -59.07
ROA % -46.99
ROIC % -55.92
ROC (Joel Greenblatt) % -458.52
ROCE % -57.86

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.43
PB Ratio 0.35
EV-to-EBIT -1.21
EV-to-EBITDA -1.44
EV-to-Revenue 1.37
EV-to-FCF -3.32
Earnings Yield (Greenblatt) % -82.79
FCF Yield % -58.92

Financials (Next Earnings Date:2024-08-13)

FRA:28L's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

PEPTONIC medical AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 3.389
EPS (TTM) (€) -0.003
Beta 8.49
Volatility % 96.35
14-Day RSI 56.78
14-Day ATR (€) 0.000038
20-Day SMA (€) 0.00028
12-1 Month Momentum % -96.55
52-Week Range (€) 0.0002 - 0.0078
Shares Outstanding (Mil) 5,755.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PEPTONIC medical AB Filings

Filing Date Document Date Form
No Filing Data

PEPTONIC medical AB Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

PEPTONIC medical AB Frequently Asked Questions

What is PEPTONIC medical AB(FRA:28L)'s stock price today?
The current price of FRA:28L is €0.00. The 52 week high of FRA:28L is €0.01 and 52 week low is €0.00.
When is next earnings date of PEPTONIC medical AB(FRA:28L)?
The next earnings date of PEPTONIC medical AB(FRA:28L) is 2024-08-13.
Does PEPTONIC medical AB(FRA:28L) pay dividends? If so, how much?
PEPTONIC medical AB(FRA:28L) does not pay dividend.

Press Release

Subject Date
No Press Release